chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The evening of the day I got the shot, at 9:00 pm I started having heavy chills and shaking. It came upon me like I had hit a brick wall. My temperature went to 102.5 F. Muscle aches, headache, miserable. I took 325 m TYLENOL that evening, then several times on the 22nd and 23rd. The fever ebbed up and down for 48 hours between 99F and 102F. As I type this up, it is the 25th. I no longer have a fever, however, I am still weak.
A report received from a healthcare professional on 08Nov02, concerning an 85 year old female vaccinee who received Fluvirin on 08Nov02, 15 days after receiving another influenza vaccine (brand unspecified) on 24Oct02. On 24Oct02 the vaccinee received one dose of influenza vaccine (brand unspecified) at a doctor's office outside of the nursing home. The vaccinee did not report this vaccination to the medical staff at the nursing home and on 08Nov02 the vaccinee inadvertently received Fluvirin at the nursing home. The vaccinee did not experience any adverse event. The reporter has assessed the relationship of the vaccine to the event as unclassifiable.
Patient developed herpes zoster approximately 1 week after Zostavax.  Zoster on right trunk.  Treated with Valacyclovir 1000 tid
Pt called call center 4/29/21. Per pt, she received Moderna covid-19 vaccine on 4/28/21 in left arm. Pt said, she discovered a lump around left neck the evening of 4/28/21. Pt said, lump has increased this morning. Per pt, it looks round and hurts when touched. Pt also reported feeling tired. Pt has urgent care visit scheduled with provider today, 4/29/21
Extreme pain in arm.  Unable to move arm due to pain.  Pain present without moving arm.  Ice pack, Vicodin.  The next day only hurt if moved.  Pain on scale of 1-10 was a 9.
After getting the 1st dose of Pfizer I was fine the only real side affect I had was that my arm hurt badly. After my second dose my arm initially didn?t hurt but started to hurt hours later. I had cough and sore throat but the worse thing was I woke up with super puffy red eyes with green discharge coming out. I was fine until I got the Pfizer vaccine. The morning after I felt terrible. I called my doctor to see what he can do or prescribe for my eyes.
Pt received second Hep A vaccine about 4pm in pediatrician's office without immediate effect.  The next day at about 6 pm (26 hrs later) pt had a generalized seizure lasting at least 45 min that required Diastat then IV Ativan to control.  Fever of 104.6 F rectal in ER.  Normal CT of head, lumbar puncture/CSF analysis, blood/urine/CSF cx.  Pt received 48 hours of Rocephin, inpatient at hospital for 24 hours and recovered apparently fully.  EEG normal.  8/12/09 MR received for DOS   with DX:  Complex Febrile Seizure.  Pt presented after prolonged (on & off for ~45 minutes) seizure activity.  Agitated and crying upon arrival to ED.  PE (+) for post-ictal state, red TMs bilat, and occ tremor.
This spontaneous report as received from a registered nurse refers to a 12 month old patient (gender unspecified). On 03-MAR-2013 the patient was vaccinated with PROQUAD (Merck) and VARIVAX (Merck). Lot # and administration route was not provided. No adverse symptoms reports. it was unspecified if the patient sought medical attention. Additional information has been requested.
Inconsolable crying for 3 hours. No fever reported; complaints of fussiness. Parent called doctor and more Tylenol was ordered. (DT given 1/30/04 with no problems.)
One month after having my second covid vaccine, I had the worse menstrual cycle of my life. I had heavy bleeding for 4 days and horrible menstrual cramps. So bad that motrin/tylenol did not take away the pain. Also passed a lot of clots.   Also after my period, I've had continual bleeding/spotting. I've even gone to the OBGYN to get checked. I'm still bleeding...
9/1 Laryngitis, SOB, cough, difficulty taking deep breath, sore left arm, upper chest tightness 9/2 prescribed medrol pack, albuterol inhaler, told to take Benadryl and Tylenol, use smart vest(haven?t needed to use in 2 years) 9/7 was told to file incident report at work 9/12 seen at Urgent Care for worker?s comp claim,  out of work til eval by pulmonologist  9/16 eval by pulmonologist, another round tapered prednisone, continue albuterol, Benadryl and Tylenol as needed  10/3 still SOB, difficult taking deep breath, cough, upper chest tightness, sound ?chesty?
Developed Varicella 03/21/2000. Vesicles on body. Mild elevated temperature.
My daughter received her 3rd HPV injection/vaccination. Within two months, she experienced several months of unexpected, sporadic, leg weakness, falling down, leg giving out on her, tired, weak, knee gave out, fall over, cant stand up for too long, general weakness and fatigue. Missed school, peers laughed and ridiculed her at school during episodes, teachers viewed her and reported her as a distraction. Emotional distress with trying to fit into the new school while trying to control adverse events from occurring in front of complete strangers. Adverse reactions occurred at home but mostly in school when walking, changing classes all day.
The patient said that her arm, in the vaccination site, was itchy (no bumps, redness or swelling). Topical Benadryl was recommended and the situation resolved.
Felt hot and started coughing and had trouble breathing and swallowing about 10 minutes after the vaccine was given.  Was then taken from holding area of vaccine in the hospital to the ER.  Saw NP and was later released after breathing was under control and able to swallow easier.  They also checked my blood glucose to see if that had been an issue but is was 112 so it wasn't a factor.
When presenting for vaccination the patient reported to the healthcare providers that were administering the COVID-19 booster doses of Pfizer BioNTech's COVID-19 vaccine that he had completed the initial vaccination series with the Pfizer-BioNTech COVID-19 vaccine more than 6 months ago.  Due to not having internet access at the site the patient's word was taken after the staff at the facility reported that the patient did not have any cognitive impairments.  After the patient received the vaccine and returned to his apartment he informed the nursing home staff that he had received the Moderna COVID-19 vaccine for his initial vaccination series on 12/23/20 and 1/20/21 and showed the facility staff the vaccination card in his apartment.  Patient did not report any symptoms, but this error is being reported since he was not eligible for a booster vaccine.
This case was reported by a consumer and described the occurrence of allergic reaction in a 66-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline).  A physician or other health care professional has not verified this report.  The subject's medical history included acid reflux, chronic obstructive pulmonary disease, high cholesterol, menopausal and slow thyroid.  Concurrent medications included SYNTHROID, FORADIL, SPIRIVA, Lotrel, PREMARIN and NEXIUM.  In 2006, the subject received a dose of Influenza vaccine (unknown, left arm).  In 2006, 1 to 2 days after vaccination with Influenza vaccine, the subject experienced allergic reaction, swelling, erythema, pain and phlebitis.  The subject reported that within a day or two after receiving an unknown brand of flu vaccine with mercury in it, she experienced swelling and redness from almost her shoulder to her elbow with aching.  She also reported a form of phlebitis.  She did not consult her physician about this but just happened to be in a pediatrician's office with someone else and a nurse there told her to use ice.  She used ice packs for two days, including having to sit up all night.  After two days, the symptoms resolved.  In 2006, the events were resolved.
Cellulitis left upper arm anterior to smallpox vaccination site 1.5cm wide x 10cm long. Rx with PO antibiotics for 10 days  (Keflex). (+) enlarged left axillary lymph nodes - tender.
Pt recvd a series of Engerix-B on 14MAR91, 26APR91, 16SEP91 & upon completion of series pt was discovered to have not responded;
Auto Accident - syncope - Ambulanced to Hospital.  Passed out and hit a tree, totaled vehicle with no memory of the event.  CT without contrast, blood work, EKG, fluid given IV. Stayed about 3 hours and was released.
9Apr92 approx 3-4 days p/ vax pt exp chills, fever, inc WBC, welts all over body (worse in PM), asthma, cervical adenopathy, irritability, fatigue.Also reported being out of work.Pt hospitalized.Tx w/ meds. Outcome-some improvement-fatigue.
Injection site swelling  no pain, or reddness; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number 9AB33, expiry date 6th December 2021) for prophylaxis.   On 19th December 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site swelling. On an unknown date, the outcome of the injection site swelling was unknown.   It was unknown if the reporter considered the injection site swelling to be related to Shingrix.  Additional details were provided as follows: The pharmacy manager reported that, the patient had injection site swelling after vaccination, but no pain or redness. The reporter consented to follow up.
rt arm rash surrounding inj site rash sl raised, sl swelling, sl warm to touch;
pt recv vax & devel a fever of 101, dizziness, & a 3 inch area of erythema & swelling @ inj site;pt was treated w/ATB;
Pt recv vax on 10/6/98; 8 hr post vax pt exp chills, nausea, dry heaves, sweating, headache, ankle pain,  hot welt area of Rt arm
This spontaneous report as received from a medical assistant via company representative refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with a doses of improperly stored RECOMBIVAX HB (lot# L019298, exp. date:22-JUN-2017) (strength, route and frequency were not reported). The temperature of the storage was 50 Fahrenheit degree for 24 hours. No adverse symptoms were reported. The outcome of the patient's event was not reported. This is one of several reports from the same source. Additional information has been requested.
rash at the injection site, body aches, fatigue, joint pain, swollen lymph nodes on both sides of the neck and in the right armpit,  fever (99.8F-100.4F)
When the patient returned for her second vaccine dose she reported an ASE and she has not filed a report. The patient reported that about 10 days after receiving her first Moderna COVID-19 vaccine her left deltoid suddenly had a rash develop overnight. The rash covered her left deltoid and upper arm,  the rash did not spread down to her left elbow. The patient reported the symptoms were mild and denied itching or pain. Patient stated that symptoms resolved within 24 hours after first developing.
Inpatient - 4 days 11/14-11/18/21 Patient is a woman with past medical history significant for acute PE July 2021 currently  morbid obesity, OSA on CPAP presenting with progressive shortness of breath.  Patient states that over the past 3 days, she has experienced increasing shortness of breath.  Patient also has persistent dry cough, intermittent fevers, body aches, diarrhea as well as nausea vomiting.  Patient has also lost her sense of taste and smell.  Patient has also had a poor appetite and has lost around 10 lb.  In the emergency department, T-max 38.2°.  Heart rate 113. O2 sat was 90% on room air with respiratory rate around 20. Lab showed a sodium 113, blood glucose 335 and the rest of her CMP was within normal limits.  Complete blood count unremarkable.  D-dimer elevated at 670. CT angiogram performed but read is pending at the time of this note.  COVID-19 PCR was positive.  Patient was given a dose of Decadron and transfer the hospitalist service.  During the hospitalization initially was on empiric antibiotic of ceftriaxone, azithromycin as well as dexamethasone, antibiotics were discontinued as there was low clinical concern of bacterial pneumonia, her dexamethasone was discontinued because her oxygen requirement improved she was satting 100% on room air.  Otherwise hospital course was mostly unremarkable, shortness of breath improved, doing well discharge home today in stable condition, recommended getting COVID booster shot in next 3-4 weeks, instruction discussed in detail with patient she verbalized understanding.
Had the shot. the year after it came out four times/Suspected vaccination failure; I have had them four times; Now have meds that can help with the pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (the patient was getting mild cases of shingles).   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 09-AUG-2022 Reporter's Comment: This case was reported by a patient via  interactive digital media. The patient had shingles shot but he/she was getting mild cases before that. The patient did not have covid shot. The patient got the shingles shot and had them four times shingles.  They now had meds that could help with the pain and the duration time. The patient had the shingles shot and the year after shingles came out .  The patient had them four times since then. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
rash size of an orange; blotchy place size of an orange; injection site redness; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (sore arm), RASH MACULAR (blotchy place size of an orange), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE RASH (rash size of an orange) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included ASCORBIC ACID, BETACAROTENE, COPPER, NICOTINAMIDE, SELENIUM, TOCOPHEROL, XANTOFYL, ZINC (LUTEIN +) for Eye discomfort, MULTIVITAMINS [VITAMINS NOS] and ASCORBIC ACID, BIOFLAVONOIDS NOS, HESPERIDIN, MALPIGHIA GLABRA, ROSA CANINA, RUTOSIDE (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS;HESPERIDIN;MALPIGHIA GLABRA;ROSA CANINA;RUTOSIDE]) for an unknown indication.  On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 12-Jan-2021, the patient experienced AXILLARY PAIN (sore arm). On 25-Jan-2021, the patient experienced RASH MACULAR (blotchy place size of an orange) and VACCINATION SITE ERYTHEMA (injection site redness).   On an unknown date, the patient experienced VACCINATION SITE RASH (rash size of an orange). The patient was treated with CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL [CAMPHOR;DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) for Rash, at an unspecified dose and frequency. On 15-Jan-2021, AXILLARY PAIN (sore arm) outcome was unknown.   At the time of the report, RASH MACULAR (blotchy place size of an orange), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE RASH (rash size of an orange) had not resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Patient's concomitant medication included Heart med and Betablockers.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm at the injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at the injection site). On 12-Feb-2021, VACCINATION SITE PAIN (Sore arm at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded.  Vaccination site pain is consistent with the product safety profile.
Bad headache; Hives; This is a spontaneous report received from a contactable consumer. A female patient of an unspecified age received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number and expiration date: not reported), via an unspecified route of administration on an unspecified date as unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced bad headache and hives on an unspecified date. The outcome of events was unknown.  Additional Context: The patients youngest son had a doctor's appointment and his GI doctor told the patient that headache was common and would go away and that she also had a bad headache. That was just her sons GI doctor that told her the headache was fine. The patient sent an e-mail to her PCPC asking about the hives.  Information about lot/batch number has been requested.
Severe chills, fatigue,  shivering.  Unable to do daily activities.  Symptoms started 5 days after the COVID vaccine and have lasted for 7 days so far.
Throat from vocal folds to clavicle was closing, difficulty breathing, difficulty swallowing, slight dizziness - arrived at ER at approx. 3:30 - was given 50 mg of Benadryl & monitored for approx 1.25 hours - breathing returned to normal - instructed to self administer 25-50 mg of Benadryl as needed at 6 hour intervals - took 25 mg at approx. 10:00 and was fine, then had same severity of onset as initial reaction at approx. 4:00 a.m. (10-29-09) and had to take 50 mg to get breathing back to normal. Went to ob/gyn next morning (10-29-09)for 9:00 a.m. and was given a cortisone shot to help with the recurring reactions, also had baby examined through fetal ultrasound and fetal heartbeat monitor. Had to take 25mg of Bendadryl at approx. 10:00 p.m. that night b/c entire lung area (sternum, ribs & thoracic spine) was under severe pressure and it hurt to breathe. After 1/2 hour, pain subsided - after 45 minutes could lay down to try to sleep. No further reractions so far today (10/30/09 @ 12:10 p.m.) but instructed by ob/gyn to keep the Benadryl with me at all times b/c allergic reactions can last for up to 2 weeks. I HAVE NO ALLERGIES TO EGGS!  11/02/09 and 11/03/09  Medical records received for DOS 10/28/09. Final DX: Adverse reaction to influenza vaccine.  20 week gestation patient developed feeling of throat swelling 1hr s/p vaccine.  PE unremarkable. Benadryl and observation x1hr. Pos fetal heart tones. No change in sx.  Discharged.
Expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 1-year-old male patient who received HAV (Havrix) (batch number F7X23, expiry date 25-MAY-2023) for prophylaxis.   On 31-MAY-2023, the patient received Havrix. On 31-MAY-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired dose administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 31-May-2023 The healthcare professional called to inform that earlier that day, a patient received an expired dose of Havrix, which led to expired vaccine used. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
Spontaneous total loss of vision in right eye. Blood clot formed and had stroke. CRAO--Central Retina Arterial Occlusion; will not recover use of eye. All tests have turned out normal
Pt, a resident of a long-term care facility, devel flu-like resp sx p/being administered influenza vax; This necessitated a MD visit;
Patient received the plain pfizer vaccine instead of the Pfizer bivalent dose. Intended shot--Pfizer Bivalent
Pt received MENACTRA Vaccine instead of KINRIX vaccine. 7/23/18 4:22pm manufacturer notified.
Tested positive for COVID-19; Tested positive for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Jan2021 as dose 1, single (Lot number: EN5318), in left arm, on 17Feb2021 as dose 2, single (Lot number: EN5318), in left arm and on 22Oct2021 as dose 3 (booster), single (Lot number: EW0217) at the age of 42 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: No, reaction(s): "Allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 11Jan2022, outcome "recovered" and all described as "Tested positive for COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30Jan2022) Positive, notes: covid test type post vaccination=Nasal Swab, covid test name post vaccination=On/Go. Therapeutic measures were not taken as a result of vaccination failure, covid-19. Clinical course: Patient was not taken any other vaccine in four weeks and other medications in two weeks.
Patient received 3rd dose Pfizer/Comirnaty dose too early.  Last dose reported by patient was 6/24/2021, next dose should have been due 12/24/2021 per current guidelines.  Patient aware and no current effects noted.
Itching, welts, tongue felt funny, went to Urgent Care and was given Epi and 5 days of Prednisone
Patient received ADACEL and MENACTRA in our office. He was calm while getting vaccines. At the check out counter he passed out and Mom described "stiffened seizure activity". He recovered in our office and returned home.